Mid and Standard Frequency Ventilation in Infants With Respiratory Distress Syndrome (MIDAS)
Primary Purpose
Ventilator-Induced Lung Injury, Respiratory Distress Syndrome, Bronchopulmonary Dysplasia
Status
Active
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Mid frequency ventilation
Standard frequency ventilation
Sponsored by
About this trial
This is an interventional treatment trial for Ventilator-Induced Lung Injury
Eligibility Criteria
Inclusion Criteria:
- Infants ≥ 23+0/7 weeks and ≤ 36+6/7 who are intubated and mechanically ventilated for respiratory distress syndrome (defined by use of surfactant) within 48 hours after birth
- Infants whose parents/legal guardians have provided consent for enrollment
- Inborn or outborn infants transferred to this center before 48 hours after birth
- Ventilator rate ≤ 80 per minute prior to enrollment
Exclusion Criteria:
- a major malformation, a neuromuscular condition that affects respiration, or terminal illness or decision to withhold or limit support.
Sites / Locations
- University of Alabama at Birmingham
- University of South Alabama
Arms of the Study
Arm 1
Arm 2
Arm Type
Other
Other
Arm Label
Mid frequency ventilation
Standard frequency ventilation
Arm Description
Mid frequency ventilation delivered at rates > 60 per minute and ≤ 150 per minute, with patient triggered ventilation and pressure support.
Standard frequency ventilation delivered at rates < 60 per minute and ≥ 20 per minute, with patient triggered ventilation and pressure support.
Outcomes
Primary Outcome Measures
Alive ventilator free days
The number of days alive and ventilator-free
Secondary Outcome Measures
Alive at day 28 after birth
Number of infants alive
Ventilator free
Number of infants ventilator free
Bronchopulmonary dysplasia
Bronchopulmonary dysplasia in preterm infants less than 32 weeks' gestation
Bronchopulmonary dysplasia
Bronchopulmonary dysplasia in preterm infants less than 29 weeks' gestation
Air leak syndrome
Rate of pulmonary interstitial emphysema and/or pneumothorax
Pulmonary hemorrhage
Rate of pulmonary hemorrhage
Severe (grade 3-4) intracranial hemorrhage
Rate of severe (grade 3-4) intracranial hemorrhage in infants less than 29 weeks' gestation
Alive and continuous positive airway pressure/ventilator free
Number of days alive and ontinuous positive airway pressure/ventilator free
Alive and oxygen free
Number of days alive and oxygen free
Postnatal steroids
Rate of post natal steroids for bronchopulmonary dysplasia
Necrotizing enterocolitis
Rate of proven necrotizing enterocolitis (NEC) in infants less than 29 weeks' gestation
Neurodevelopmental impairment
Rate of moderate to severe neurodevelopmental impairment in survivors < 27 weeks' gestation
Bronchopulmonary dysplasia or death
Rate of Bronchopulmonary dysplasia or death
Neurodevelopmental impairment or death
Rate of Bronchopulmonary dysplasia or death
Bronchopulmonary dysplasia or death
Rate of moderate to severe neurodevelopmental impairment or death
Necrotizing enterocolitis or death
Rate of proven necrotizing enterocolitis or death
Death
Death before hospital discharge
Full Information
NCT ID
NCT03231735
First Posted
July 25, 2017
Last Updated
October 4, 2023
Sponsor
University of Alabama at Birmingham
Collaborators
University of South Alabama
1. Study Identification
Unique Protocol Identification Number
NCT03231735
Brief Title
Mid and Standard Frequency Ventilation in Infants With Respiratory Distress Syndrome
Acronym
MIDAS
Official Title
A Randomized Controlled Trial of Mid and Standard Frequency Ventilation in Infants With Respiratory Distress Syndrome
Study Type
Interventional
2. Study Status
Record Verification Date
October 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
August 2, 2017 (Actual)
Primary Completion Date
November 21, 2021 (Actual)
Study Completion Date
October 31, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Alabama at Birmingham
Collaborators
University of South Alabama
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study is to determine, in preterm infants less than 37 weeks gestation with respiratory distress who are ventilated in the first 48 hours after birth, if mid frequency ventilation strategy using ventilator rate of ≥ 60 to ≤ 150 per minute compared with standard frequency ventilation strategy using ventilator rates of ≥ 20 to < 60 per minute will increase the number of alive ventilator-free days after randomization and reduce the risk of ventilator induced lung injury.
Detailed Description
In preterm infants with respiratory distress syndrome (RDS) who are ventilated in the first 48 hours after birth, mid frequency ventilation (MFV) strategy, compared with standard frequency ventilation (SFV) strategy, in the first week after birth, will increase the number of days alive and ventilator-free in the 28 days after birth.
This will be a randomized controlled trial with a 1:1 parallel allocation of infants to MFV or SFV using stratified permuted block design. Randomization will be stratified by gestational age (≥ 23 weeks to ˂ 26 weeks, ≥ 26 weeks to ≤ 28+6/7 (less than 29 weeks), and 29+0/7 to 36+6/7). Randomization of twins and higher orders (when eligible) will be to the same group.
Inborn and outborn infants who are receiving assisted ventilation for RDS in the first 48 hours after birth will be included in this study. Infants with any of the following: a major malformation, a neuromuscular condition that affects respiration, terminal illness or decision to withhold or limit support will not be eligible.
Infants will be randomized to MFV versus SFV. MFV delivered at rates > 60 per minute and ≤ 150 per minute, with patient triggered ventilation and pressure support.
SFV delivered at rates < 60 per minute and ≥ 20 per minute, with patient triggered ventilation and pressure support.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Ventilator-Induced Lung Injury, Respiratory Distress Syndrome, Bronchopulmonary Dysplasia, Preterm Infant
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 2, Phase 3
Interventional Study Model
Parallel Assignment
Model Description
This will be a randomized controlled trial with a 1:1 parallel allocation of infants to mid or standard frequency ventilation using stratified permuted block design.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
60 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Mid frequency ventilation
Arm Type
Other
Arm Description
Mid frequency ventilation delivered at rates > 60 per minute and ≤ 150 per minute, with patient triggered ventilation and pressure support.
Arm Title
Standard frequency ventilation
Arm Type
Other
Arm Description
Standard frequency ventilation delivered at rates < 60 per minute and ≥ 20 per minute, with patient triggered ventilation and pressure support.
Intervention Type
Device
Intervention Name(s)
Mid frequency ventilation
Intervention Description
Mechanical ventilator used at rates > 60 per minute and ≤ 150 per minute, with patient triggered ventilation and pressure support.
Intervention Type
Device
Intervention Name(s)
Standard frequency ventilation
Intervention Description
Mechanical ventilator used at rates < 60 per minute and ≥ 20 per minute, with patient triggered ventilation and pressure support.
Primary Outcome Measure Information:
Title
Alive ventilator free days
Description
The number of days alive and ventilator-free
Time Frame
Days 1-28 after birth
Secondary Outcome Measure Information:
Title
Alive at day 28 after birth
Description
Number of infants alive
Time Frame
Day 28 after birth
Title
Ventilator free
Description
Number of infants ventilator free
Time Frame
Day 28 after birth
Title
Bronchopulmonary dysplasia
Description
Bronchopulmonary dysplasia in preterm infants less than 32 weeks' gestation
Time Frame
Measured at 36 weeks' postmenstrual age
Title
Bronchopulmonary dysplasia
Description
Bronchopulmonary dysplasia in preterm infants less than 29 weeks' gestation
Time Frame
Measured at 36 weeks' postmenstrual age
Title
Air leak syndrome
Description
Rate of pulmonary interstitial emphysema and/or pneumothorax
Time Frame
Day 1-28 after birth
Title
Pulmonary hemorrhage
Description
Rate of pulmonary hemorrhage
Time Frame
Day 1-28 after birth
Title
Severe (grade 3-4) intracranial hemorrhage
Description
Rate of severe (grade 3-4) intracranial hemorrhage in infants less than 29 weeks' gestation
Time Frame
Day 1-30 after birth
Title
Alive and continuous positive airway pressure/ventilator free
Description
Number of days alive and ontinuous positive airway pressure/ventilator free
Time Frame
Day 1-28 after birth
Title
Alive and oxygen free
Description
Number of days alive and oxygen free
Time Frame
Day 1-28 after birth
Title
Postnatal steroids
Description
Rate of post natal steroids for bronchopulmonary dysplasia
Time Frame
Before 36 weeks' postmenstrual age
Title
Necrotizing enterocolitis
Description
Rate of proven necrotizing enterocolitis (NEC) in infants less than 29 weeks' gestation
Time Frame
Days 1-120 after birth
Title
Neurodevelopmental impairment
Description
Rate of moderate to severe neurodevelopmental impairment in survivors < 27 weeks' gestation
Time Frame
18 to 24 months after birth
Title
Bronchopulmonary dysplasia or death
Description
Rate of Bronchopulmonary dysplasia or death
Time Frame
Day 1-120 after birth
Title
Neurodevelopmental impairment or death
Description
Rate of Bronchopulmonary dysplasia or death
Time Frame
Day 1-120 after birth
Title
Bronchopulmonary dysplasia or death
Description
Rate of moderate to severe neurodevelopmental impairment or death
Time Frame
18 to 24 months after birth
Title
Necrotizing enterocolitis or death
Description
Rate of proven necrotizing enterocolitis or death
Time Frame
Day 1-120 after birth
Title
Death
Description
Death before hospital discharge
Time Frame
Day 1-120 after birth
10. Eligibility
Sex
All
Minimum Age & Unit of Time
1 Day
Maximum Age & Unit of Time
3 Days
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Infants ≥ 23+0/7 weeks and ≤ 36+6/7 who are intubated and mechanically ventilated for respiratory distress syndrome (defined by use of surfactant) within 48 hours after birth
Infants whose parents/legal guardians have provided consent for enrollment
Inborn or outborn infants transferred to this center before 48 hours after birth
Ventilator rate ≤ 80 per minute prior to enrollment
Exclusion Criteria:
a major malformation, a neuromuscular condition that affects respiration, or terminal illness or decision to withhold or limit support.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Waldemar A Carlo, MD
Organizational Affiliation
University of Alabama at Birmingham
Official's Role
Study Director
Facility Information:
Facility Name
University of Alabama at Birmingham
City
Birmingham
State/Province
Alabama
ZIP/Postal Code
35249
Country
United States
Facility Name
University of South Alabama
City
Mobile
State/Province
Alabama
ZIP/Postal Code
36604
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Mid and Standard Frequency Ventilation in Infants With Respiratory Distress Syndrome
We'll reach out to this number within 24 hrs